Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 84.72 USD -0.22% Market Closed
Market Cap: 11.5B USD
Have any thoughts about
Globus Medical Inc?
Write Note

Intrinsic Value

The intrinsic value of one GMED stock under the Base Case scenario is 85.38 USD. Compared to the current market price of 84.72 USD, Globus Medical Inc is Undervalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GMED Intrinsic Value
85.38 USD
Undervaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Globus Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GMED?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Globus Medical Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Globus Medical Inc

Provide an overview of the primary business activities
of Globus Medical Inc.

What unique competitive advantages
does Globus Medical Inc hold over its rivals?

What risks and challenges
does Globus Medical Inc face in the near future?

Has there been any significant insider trading activity
in Globus Medical Inc recently?

Summarize the latest earnings call
of Globus Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Globus Medical Inc.

Provide P/S
for Globus Medical Inc.

Provide P/E
for Globus Medical Inc.

Provide P/OCF
for Globus Medical Inc.

Provide P/FCFE
for Globus Medical Inc.

Provide P/B
for Globus Medical Inc.

Provide EV/S
for Globus Medical Inc.

Provide EV/GP
for Globus Medical Inc.

Provide EV/EBITDA
for Globus Medical Inc.

Provide EV/EBIT
for Globus Medical Inc.

Provide EV/OCF
for Globus Medical Inc.

Provide EV/FCFF
for Globus Medical Inc.

Provide EV/IC
for Globus Medical Inc.

Show me price targets
for Globus Medical Inc made by professional analysts.

What are the Revenue projections
for Globus Medical Inc?

How accurate were the past Revenue estimates
for Globus Medical Inc?

What are the Net Income projections
for Globus Medical Inc?

How accurate were the past Net Income estimates
for Globus Medical Inc?

What are the EPS projections
for Globus Medical Inc?

How accurate were the past EPS estimates
for Globus Medical Inc?

What are the EBIT projections
for Globus Medical Inc?

How accurate were the past EBIT estimates
for Globus Medical Inc?

Compare the revenue forecasts
for Globus Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Globus Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Globus Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Globus Medical Inc compared to its peers.

Compare the P/E ratios
of Globus Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Globus Medical Inc with its peers.

Analyze the financial leverage
of Globus Medical Inc compared to its main competitors.

Show all profitability ratios
for Globus Medical Inc.

Provide ROE
for Globus Medical Inc.

Provide ROA
for Globus Medical Inc.

Provide ROIC
for Globus Medical Inc.

Provide ROCE
for Globus Medical Inc.

Provide Gross Margin
for Globus Medical Inc.

Provide Operating Margin
for Globus Medical Inc.

Provide Net Margin
for Globus Medical Inc.

Provide FCF Margin
for Globus Medical Inc.

Show all solvency ratios
for Globus Medical Inc.

Provide D/E Ratio
for Globus Medical Inc.

Provide D/A Ratio
for Globus Medical Inc.

Provide Interest Coverage Ratio
for Globus Medical Inc.

Provide Altman Z-Score Ratio
for Globus Medical Inc.

Provide Quick Ratio
for Globus Medical Inc.

Provide Current Ratio
for Globus Medical Inc.

Provide Cash Ratio
for Globus Medical Inc.

What is the historical Revenue growth
over the last 5 years for Globus Medical Inc?

What is the historical Net Income growth
over the last 5 years for Globus Medical Inc?

What is the current Free Cash Flow
of Globus Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Globus Medical Inc.

Business Breakdown

Globus Medical Inc. is a prominent player in the expanding spinal surgery market, leveraging innovation and patient-centric solutions to elevate the standards of care in orthopedic surgery. Founded in 2003, the company has quickly established itself as a leader by developing a comprehensive range of spinal implants and surgical instruments that emphasize minimally invasive techniques. This focus not only enhances patient recovery but also supports surgeons in their pursuit of optimal outcomes. With a robust pipeline of products and a commitment to research and development, Globus Medical aims to maintain its competitive edge by addressing the evolving needs of healthcare professionals and pa...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Globus Medical Inc

Current Assets 2.1B
Cash & Short-Term Investments 694.7m
Receivables 593.2m
Other Current Assets 768.6m
Non-Current Assets 3B
Long-Term Investments 12.3m
PP&E 622.3m
Intangibles 2.3B
Other Non-Current Assets 120.4m
Current Liabilities 818.1m
Accounts Payable 57.5m
Accrued Liabilities 265.3m
Other Current Liabilities 495.3m
Non-Current Liabilities 198.6m
Long-Term Debt 709k
Other Non-Current Liabilities 197.9m
Efficiency

Earnings Waterfall
Globus Medical Inc

Revenue
2.5B USD
Cost of Revenue
-1B USD
Gross Profit
1.4B USD
Operating Expenses
-1.3B USD
Operating Income
168.6m USD
Other Expenses
-77.1m USD
Net Income
91.5m USD

Free Cash Flow Analysis
Globus Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Globus Medical saw revenues reach $625.7 million, a 63.1% increase fueled by the NuVasive merger. Non-GAAP EPS grew 45% to $0.83 with record free cash flow of $161.7 million. The U.S. Spine segment grew 55%, showcasing strong product demand and increased sales efficiency. Globus anticipates full-year sales between $2.49 billion and $2.5 billion, representing a 3.9% to 4.3% rise over the previous year. They expect gross profit margins to improve to mid-70s in the near future as integration synergies materialize. Excitingly, 2025 is forecasted as a pivotal growth year as they enhance product portfolios and expand market reach.

What is Earnings Call?
Fundamental Scores

GMED Profitability Score
Profitability Due Diligence

Globus Medical Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Exceptional 1-Year Revenue Growth
59/100
Profitability
Score

Globus Medical Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

GMED Solvency Score
Solvency Due Diligence

Globus Medical Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
84/100
Solvency
Score

Globus Medical Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GMED Price Targets Summary
Globus Medical Inc

Wall Street analysts forecast GMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMED is 92.35 USD with a low forecast of 80.8 USD and a high forecast of 105 USD.

Lowest
Price Target
80.8 USD
5% Downside
Average
Price Target
92.35 USD
9% Upside
Highest
Price Target
105 USD
24% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GMED?

Click here to dive deeper.

Dividends

Globus Medical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GMED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Globus Medical Inc Logo
Globus Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

11.5B USD

Dividend Yield

0%

Description

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2012-03-08. The company is focused on implants that promote healing in patients with musculoskeletal disorders, including the use of a robotic guidance and navigation system and products to treat orthopedic traumas. The company groups its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities as well as the hip. Its Enabling Technologies are comprised of imaging, navigation, and robotics (INR) solutions for assisted surgery. The company offers solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screw and rod systems.

Contact

PENNSYLVANIA
Audubon
2560 General Armistead Ave
+16109301800.0
www.globusmedical.com

IPO

2012-03-08

Employees

2 400

Officers

Co-Founder & Executive Chairman
Mr. David C. Paul
President, CEO & Director
Mr. Daniel T. Scavilla
CFO & COO
Mr. Keith W. Pfeil
Senior VP, General Counsel & Secretary
Ms. Kelly G. Huller Esq.
Senior Vice President of Business Development & Investor Relations
Mr. Brian J. Kearns

See Also

Discover More
What is the Intrinsic Value of one GMED stock?

The intrinsic value of one GMED stock under the Base Case scenario is 85.38 USD.

Is GMED stock undervalued or overvalued?

Compared to the current market price of 84.72 USD, Globus Medical Inc is Undervalued by 1%.

Back to Top